Antidiabetics Market to touch USD 80.0 Billion By 2024

New York, August 11, 2018: The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. 

The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period.

Ant diabetics are the drugs which stabilize the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of antidiabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels. 

Increasing number of diabetic patients is increasing the demand for antidiabetics which is a driving factor for antidiabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.

You Can Find Full Report @:  https://www.marketresearchengine.com/reportdetails/antidiabetics-market

The Antidiabetics Market has been segmented as below:

The Antidiabetics Market is Segmented on the lines of Types of Insulin, Product and Geography. By Types of Insulin this market is segmented on the basis of Rapid Acting, Long Acting, Premixed, Premixed Analog, Short Acting and Intermediate Acting.

By Product this market is segmented on the basis of Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors and Meglitinides. By Geography this market is segmented on the basis of North America, Europe,

Asia-Pacific and Rest of the World (ROW).

This report provides: 

1) An overview of the global market for antidiabetics and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry. 

Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/antidiabetics-market

Table of Contents

1.   INTRODUCTION

2.   Executive Summary

2.   Antidiabetics Industry

3.   Antidiabetics Product

4.   Antidiabetics Regional

5.   Competitive Landscape

5.1  Sanofi Aventis

5.1.1 Company Overview

5.2 Takeda Pharmaceuticals

5.3 Eli Lilly

5.4 Oramed Pharmaceuticals Inc.

5.5 Merck & Co. Inc.

5.6 Novo Nordisk

5.7 Bristol-Myers Squibb

5.8 Halozyme Therapeutics

5.9 Pfizer

6.   Methodology and Scope

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/